Serum Institute

Only Covaxin To Be Administered To Children, Registrations On CoWIN From January 1, Health Ministry

Serum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For Adults

BY PTI

Serum Institute of India

Serum Institute's Vaccine Against Cervical Cancer To Be Available In Market This Month, Priced At Rs 2000 For Two Doses

BY PTI

Cervical cancer (Representative image)

Govt Likely To Float Global Tender For HPV Vaccine In April; Merck, Serum Institute May Participate

BY PTI

In India, SII makes the Covishield and plans to also make Covovax in collaboration with Novavax. Hyderabad-based Bharat Biotech manufactures the Covaxin vaccine.

Serum Institute Seeks Drug Regulator's Approval For Market Authorisation Of Its Covid Vaccine As Booster Dose

BY PTI

Government Tells Rajya Sabha, It Cannot Be Said That Dengue, Malaria, Kala-Azar Spreading In India

DGCI Allows Serum Institute To Export Malaria Vaccine To UK

BY PTI

Serum Institute of India

SII Seeks Govt's Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical Cancer

BY Outlook Web Desk

Covovax reviewed for use in 12 year olds and above.

NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above

BY Outlook Web Desk

Advertisement

Serum Institute seeks EUA for rBcg.

Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine

BY Outlook Web Desk

SII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults

SII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults

BY Outlook Web Desk

A health worker administers Covid-19 vaccination to a girl, in New Delhi.

Nobody Losing Anything Due To COVID-19 Vaccine Mandates, Centre Tells SC

BY Outlook Web Desk

8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

BY Outlook Web Desk

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

BY Outlook Web Desk

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

BY Outlook Web Desk

PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

BY Outlook Web Desk

Advertisement

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

BY Outlook Web Desk

Covishield Gets Australian Medicine Regulator's Approval For Incoming Travellers

Covishield Gets Australian Medicine Regulator's Approval For Incoming Travellers

BY Outlook Web Desk

Centre To Receive 20 Crores Of Covishield Doses From Serum Institute In September

Centre To Receive 20 Crores Of Covishield Doses From Serum Institute In September

BY Outlook Web Desk

Centre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector Quota

Centre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector Quota

BY Outlook Web Bureau

Serum Institute Chairman Praises Modi Govt For Controlling Red-Tapism And Licence Raj

Serum Institute Chairman Praises Modi Govt For Controlling Red-Tapism And Licence Raj

BY Outlook Web Desk

‘It May Start Blame Game’: Serum Institute’s Cyrus Poonawalla Against Mixing Covid Vaccines

‘It May Start Blame Game’: Serum Institute’s Cyrus Poonawalla Against Mixing Covid Vaccines

BY Outlook Web Bureau

Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister

Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister

BY Outlook Web Desk

Advertisement

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

BY Outlook Web Desk

Not Received Marketing Authorisation Application For Covishield: EU Medical Body

Making A Difference

Not Received Marketing Authorisation Application For Covishield: EU Medical Body

BY Outlook Web Bureau

Confident That European Union Will Approve Covishield In A Month: Adar Poonawalla

Confident That European Union Will Approve Covishield In A Month: Adar Poonawalla

BY Outlook Web Bureau

Not Received Any Application Seeking Approval For Covishield: European Medicines Agency

Making A Difference

Not Received Any Application Seeking Approval For Covishield: European Medicines Agency

BY Outlook Web Bureau

load more stories

<li id="v8oko"></li>

<li id="v8oko"><tbody id="v8oko"></tbody></li>

<li id="v8oko"><dl id="v8oko"></dl></li>